Screener
Integra LifeSciences IART EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) | $4,482 | $(484,073) | $(134) | $(509,366) |
| Net income (loss) per share | ||||
| Basic | $0.06 | $(6.31) | — | $(6.65) |
| Diluted | $0.06 | $(6.31) | — | $(6.65) |
| Weighted average common shares outstanding (See Note 12): | ||||
| Basic | 77,293 | 76,695 | 77,122 | 76,579 |
| Diluted | 78,168 | 76,695 | 77,122 | 76,579 |
| Comprehensive loss (See Note 13) | (4,775) | (490,874) | (10,254) | $(512,702) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's EPS (diluted)?
- Integra LifeSciences (IART) reported EPS (diluted) of $0.06 in Q2 2026.
- How has Integra LifeSciences's EPS (diluted) changed year-over-year?
- Integra LifeSciences's EPS (diluted) increased by 101.0% year-over-year, from -$6.31 to $0.06.
- What is the long-term trend for Integra LifeSciences's EPS (diluted)?
- Over 3 years (2021 to 2025), Integra LifeSciences's EPS (diluted) has grown at a 50.4% compound annual growth rate (CAGR), from $1.98 to -$6.73.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Integra LifeSciences's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude